Eli Lilly Pitches Alzheimer Drug to the FDA, Aiming to Leapfrog Biogen

·2-min read

It's an exciting if turbulent, and rather cutthroat, time in the world of Alzheimer's drug research. In June, the FDA greenlit Biogen's...

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting